Brought to you by 
Boston Scientific gets rights to ArthroCare's Coblation
13 Jul 1999
Executive Summary
Boston Scientific has acquired exclusive rights to develop and market surgical device company ArthroCare's Coblation technology for use in myocardial revascularization.
Deal Industry
- Medical Devices
-
Medical Devices
- Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Alliance
- Includes Contract
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Boston Scientific gets rights to ArthroCare's Coblation
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice